PANRE Review Price: $399.99
Pharmacology Review Price: $399.99
Access Duration: 30 Months
Deliverables: 112 Hours of AAPA Category 1 Credit, 1,672 Board-Style Questions
For the modern Physician Assistant, the end of the fiscal year or your certification cycle often brings a common dilemma: how to effectively exhaust your CME stipend while gaining high-yield clinical knowledge. The "Pro-PA Bundle" is a strategic approach that pairs our PANRE Review Course with the Pharmacology Review Course. By bundling these two high-value resources, you maximize your educational return, secure your prescriptive authority requirements, and unlock the maximum value of the CME gift card add-on system.
Most employer-provided CME stipends range from $1,500 to $2,500. A single course often fails to reach this threshold, leaving unused funds on the table. By selecting both the PANRE Review and the Pharmacology courses, you establish a professional foundation of 112 hours of Category 1 AAPA credit.
The strategy is simple: add both courses to your curriculum and utilize the Amazon or Apple gift card add-ons to bridge the gap to your total stipend limit. These gift cards, ranging from $100 to $1,500, are included in the total package price, allowing you to enrich your professional library or upgrade your clinical hardware (like a new iPad or MacBook) while completing your required credits.
The PANRE Review Course is designed as a comprehensive deep dive into the NCCPA Blueprint. It is the primary engine for your recertification preparation.
While the PANRE course covers the broad clinical spectrum, many state boards and hospital credentialing committees require specific pharmacology-only credits for prescriptive authority.
The synergy between these two courses is unmatched. The PANRE course provides the diagnostic framework, while the Pharmacology course solidifies the management portion of the clinical encounter. When you purchase these together, you receive 30 months of access. This longevity is critical for PAs who want to revisit the material as a clinical reference long after their exam is over.
Furthermore, the gift card add-on process is seamless. Gift cards are processed within 2-3 business days and delivered via email. Whether you choose Amazon, Apple, or Best Buy, the total price is bundled into one transaction, simplifying your professional development tracking.
The following vignettes represent the level of rigor found in our 1,672-question bank. Use these to test your clinical readiness.
Your patient is a 68-year-old male presenting with a 2-day history of palpitations and mild dyspnea on exertion. He has a history of hypertension and HTN-related cardiomyopathy. Vital signs: HR 124 (irregular), BP 132/84, RR 18, SaO2 96% on RA. An EKG reveals an irregularly irregular rhythm without discernible P waves. A bedside echo shows a left atrial diameter of 5.2 cm.
What is the most appropriate next step in the long-term management of this patient’s stroke risk?
A. Aspirin 325 mg daily
B. Clopidogrel 75 mg daily
C. Apixaban 5 mg twice daily
D. Immediate synchronized cardioversion
Correct Answer: C. Apixaban 5 mg twice daily
Explanation: The patient is in atrial fibrillation. Based on the CHADS2-VASc score (Age = 1, Hypertension = 1, Heart Failure/Cardiomyopathy = 1; Total = 3), anticoagulation is indicated. Direct oral anticoagulants (DOACs) like Apixaban are preferred over warfarin or antiplatelet therapy (A and B) for stroke prevention in non-valvular A-fib. Immediate cardioversion (D) is not indicated as the patient is hemodynamically stable and the duration of A-fib is unknown; cardioversion without 3 weeks of anticoagulation or a negative TEE poses a high risk of thromboembolism, especially with a dilated left atrium.
Your patient is a 54-year-old female with Type 2 Diabetes Mellitus currently managed with Metformin 1000 mg BID. She is scheduled for an elective contrast-enhanced CT scan of the abdomen for follow-up on a renal cyst. Her baseline serum creatinine is 1.4 mg/dL (eGFR 48).
Which of the following is the most appropriate instruction regarding her Metformin?
A. Discontinue Metformin 48 hours before the procedure and restart immediately after.
B. Continue Metformin as scheduled; no adjustments needed for eGFR > 45.
C. Hold Metformin at the time of the procedure and restart 48 hours later after confirming stable renal function.
D. Switch to Glyburide permanently.
Correct Answer: C. Hold Metformin at the time of the procedure and restart 48 hours later after confirming stable renal function.
Explanation: For patients with an eGFR between 30-60, Metformin should be held at the time of or prior to the administration of iodinated contrast. It should be withheld for 48 hours following the procedure and only restarted once renal function has been re-evaluated and found to be stable. This precaution is taken to avoid the accumulation of Metformin and subsequent lactic acidosis should contrast-induced nephropathy occur. Continuing Metformin (B) in the setting of contrast and borderline renal function is risky. Glyburide (D) is not a suitable permanent replacement due to the risk of hypoglycemia.
Your patient is a 24-year-old female presenting with a cough, fever of 101.4°F, and pleuritic chest pain for 3 days. She is otherwise healthy and has no recent antibiotic use. Physical exam reveals crackles in the right lower lobe. A chest X-ray confirms a right lower lobe infiltrate.
Which of the following is the first-line outpatient treatment for this patient?
A. Levofloxacin 750 mg daily
B. Amoxicillin 1g three times daily
C. Ciprofloxacin 500 mg twice daily
D. Vancomycin 15mg/kg IV
Correct Answer: B. Amoxicillin 1g three times daily
Explanation: For a healthy outpatient with community-acquired pneumonia (CAP) and no comorbidities or risk factors for MRSA/Pseudomonas, Amoxicillin (or Doxycycline/Macrolide depending on local resistance) is recommended as first-line therapy. Respiratory fluoroquinolones (A) are typically reserved for patients with significant comorbidities or recent antibiotic use to prevent resistance. Ciprofloxacin (C) is not a "respiratory" fluoroquinolone and has poor coverage for S. pneumoniae. Vancomycin (D) is an inpatient parenteral treatment for suspected MRSA.
The "Pro-PA Bundle" is more than just a way to earn credits; it is a comprehensive clinical upgrade. By combining the 100-hour PANRE Review Course with the Pharmacology Review Course, you secure a massive 30-month access window to high-yield videos and a 1,672-question bank. Don't leave your CME stipend on the table this year: maximize your education and your gift card bonus today.
Price: $800 - $3,000 (depending on gift card add-on)Access: Lifetime access to course materialsDeliverables: 100…
Course: PANRE Review Course Price: Starting at $399.99 Access: 30 Months of Full Access Deliverables:…
For many Physician Assistants, the end of the fiscal year or the approach of a…
Preparing for the Physician Assistant National Recertification Exam (PANRE) is a significant undertaking that requires…
Maintaining certification requires a strategic approach to Continuing Medical Education (CME). For Physician Assistants, the…
Price: $599 - $2,500 (depending on gift card add-on selection)Access: LifetimeCredits: 100 Hours of AAPA…